Monopar to Present at Roth Inaugural Healthcare Opportunities Conference
Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, today announced that Chandler Robinson, MD, Monopar’s Chief Executive Officer, will present at the Roth Inaugural Healthcare Opportunities Conference
By Monopar Therapeutics Inc.
Published - Sep 28, 2022, 08:06 AM ET
Last Updated - Apr 18, 2024, 09:34 AM EDT
WILMETTE, Ill., Sept. 28, 2022 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, today announced that Chandler Robinson, MD, Monopar’s Chief Executive Officer, will present at the Roth Inaugural Healthcare Opportunities Conference.
Presentation Details:
Date: October 6, 2022
Time: 12:00 p.m. (ET)
Location: The Yale Club, New York City, New York
